T. A. Sohn

Tumor-suppressive pathways in pancreatic carcinoma.

Ester Rozenblum, Mieke Schutte, Michael Goggins et al. · PubMed · 1997 · 699 citations

Medicine, Genetics, Oncology +17

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Metin Tascilar, Halcyon G. Skinner, Christophe Rosty et al. · PubMed · 2001 · 310 citations

Medicine, Oncology, Pathology +17

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Michael Goggins, G. J. A. Offerhaus, Werner Hilgers et al. · PubMed · 1998 · 271 citations

Medicine, Oncology, Pathology +16

A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

Gloria H. Su, T. A. Sohn, Byungwoo Ryu et al. · PubMed · 2000 · 191 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +15

Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.

Ralph H. Hruban, Patrick Sturm, Robbert J.C. Slebos et al. · PubMed · 1997 · 34 citations

Medicine, Molecular Genetics, Oncology +16